Gainers
- Bonanza Creek Energy Inc (NASDAQ: BCEI) shares rose 28.7 percent to $1.160 in pre-market trading after receiving a notice from the NYSE. Continued listing standards require for the stock's trailing 30-day average closing price to stand above $1.00. The NYSE provides a six-month cure period, over which the company plans to return to compliance, spokespeople said.
- Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) shares rose 11 percent to $2.93 in pre-market trading as the company disclosed that fostamatinib, its oral spleen tyrosine kinase inhibitor, met the primary endpoint in the final stage trial program for adult chronic/persistent immune thrombocytopenia treatment.
- Skypeople Fruit Juice Inc (NASDAQ: SPU) rose 8.6 percent to $10.32 in pre-market trading after surging 58.33 percent on Monday.
- Kamada Ltd (NASDAQ: KMDA) rose 7.3 percent to $4.86 in pre-market trading as the company disclosed favorable top-line results of its second stage trial on inhaled Alpha-1 Antitrypsin that met primary endpoint.
- Sophiris Bio Inc (NASDAQ: SPHS) rose 3.9 percent to $3.50 in the pre-market trading session. Piper Jaffray initiated coverage on Sophiris Bio with an Overweight rating.
- DSW Inc. (NYSE: DSW) shares rose 3.6 percent to $26.95 in pre-market trading after the company reported upbeat second-quarter results.
- Conatus Pharmaceuticals Inc (NASDAQ: CNAT) rose 3.5 percent to $2.07 in pre-market trading after gaining 4.17 percent on Monday.
- United Continental Holdings Inc (NYSE: UAL) rose 3.3 percent to $48.51 in the pre-market trading driven by the announcement that it named Scott Kirby as its new President. Kirby previously served as American Airlines Group Inc’s President.
- Mondelez International Inc (NASDAQ: MDLZ) rose 3.2 percent to $44.42 in pre-market trading as the company said it was no longer in talks to acquire Hershey Co as they had found no actionable path to an agreement.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Losers
- ScanSource, Inc. (NASDAQ: SCSC) shares fell 16.9 percent to $35.50 in pre-market trading after the company reported downbeat Q4 results and issued a weak forecast for the current quarter.
- G-III Apparel Group, Ltd. (NASDAQ: GIII) shares fell 13.8 percent to $36.00 in pre-market trading as the company reported weaker-than-expected results for its second quarter and lowered its full-year guidance.
- Abercrombie & Fitch Co. (NYSE: ANF) shares fell 11.8 percent to $20.25 in pre-market trading after the company reported a wider-than-expected Q2 loss.
- Hershey Co (NYSE: HSY) fell 11.3 percent to $99.05 in pre-market trading after Mondelez International Inc said it was no longer in talks to acquire it as they had found no actionable path to an agreement.
- American Airlines Group Inc (NASDAQ: AAL) shares fell 2.1 percent to $35.40 in pre-market trading. American Airlines named Robert Isom as President.
- Apple Inc. (NASDAQ: AAPL) shares fell 1.3 percent to $105.46 in pre-market trading after the European Union slapped the company with a whopping 13 billion euro ($14.5 billion) bill for back taxes. The EU concluded that Ireland gave Apple illegal state aid over many years.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.